E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/21/2006 in the Prospect News Biotech Daily.

Serono retained at buy by Merrill

Serono SA was retained by Merrill Lynch analyst Erica Whittaker at a buy. Merrill increased its 2006 earnings-per-share estimate by 9% to $45.5 from $41.9 based on better-than-expected first-quarter results. Shares of the Geneva, Switzerland, biotechnology company were up 45 cents, or 2.76%, at $16.77 on volume of 514,600 shares versus the three-month running average of 200,532 shares. (NYSE: SRA)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.